That prohibition on ordering controlled substances via e-prescribing compels physicians who e-prescribe to maintain a separate paper-and-fax system for controlled substances. Healthcare executives contend the situation has created a nuisance for e-prescribers and has discouraged wider adoption of e-prescribing.
In June 2008, the DEA addressed the controlled substances issue in a notice of proposed rule making. The agency spelled out the conditions under which e-the prescribing of controlled substances would be permitted. Those stipulations included a requirement that practitioners use two-factor authentication to access an e-prescribing application to sign controlled substance prescriptions.
Two-factor authentication rests on something a user knows -- user ID and password, for example, and a second factor. In the case of the proposed rule, that additional factor could take two forms: a multifactor one-time password device or a multifactor cryptographic device stored on a hard token.
Public comments on the proposed rule questioned the DEA’s two-factor authentication approach, with some commenters asking DEA to allow alternative authentication methods. DEA’s interim final rule hews to its 2008 effort in that it continues to require two-factor authentication. But in a departure for the earlier rule, DEA now supports biometrics as an option for the second factor.
“Two of three factors must be used: a biometric, a knowledge factor (e.g., password), or a hard token,” according to the rule. “While DEA is uncertain about the extent to which existing biometric readers will be used in healthcare settings, DEA believes it is reasonable to allow for such technology because the technology is likely to improve.”
The rule does not require the use of a specific form of biometric technology. DEA, however, said it is establishing standards for biometric systems in conjunction with the National Institute of Standards and Technology. In a prepared statement, Sen. Sheldon Whitehouse (D-R.I.), called the e-prescribing of controlled substances the “key to unleashing the vast cost saving and quality improvement potential of health information technology.”
Whitehouse said the interim rule “brings us one step closer to that goal,” while maintaining rigorous controls to prevent illegal diversion and protect privacy. The final rule will go into effect following a 60-day comment period. The Office of Management and Budget, which has been following the DEA’s rule making, has signed off on the e-prescribing rule.
Every one remembers that life seems to be very expensive, nevertheless we need money for various things and not every person earns enough cash. Thence to receive quick loan and just bank loan should be a proper way out.
Posted by: GlendaMorrow32 | June 21, 2010 at 03:52 PM
Life is a struggle, accept it.
Posted by: Air Jordans | November 11, 2010 at 02:07 AM
palm vein technology is a very reliable product from M2sys technology. Fujitsu developed the technology and m2sys provides the software.
www.m2sys.com
Posted by: john senders | January 07, 2011 at 10:03 AM
A lot of specialists say that loans aid people to live the way they want, because they can feel free to buy needed stuff. Moreover, some banks offer credit loan for different classes of people.
Posted by: loans | July 18, 2011 at 06:53 AM
When I was young, I always like to play some online games, now think it is a waste of life. But now the Internet, I would pay more attention to your thoughts and life, as it is now for me at home drinking coffee and smoking a cigar at your article
Posted by: Prada Outlet | November 16, 2011 at 10:23 PM
I love your blog very much, more more info, I will concern it again!
Posted by: mulberry alexa outlet | November 24, 2011 at 01:53 PM
Oh~What i got a great idea over here,now thanks for you sharing and say hope see you nice article in next time!~~~
Posted by: Christian Louboutin Sale | December 19, 2011 at 01:54 AM
“Great stuff. Do you have an RSS feed I can subscribe to?”
Posted by: Chanel Outle | December 19, 2011 at 03:55 AM